Weiwei Huang

3.1k total citations
76 papers, 2.4k citations indexed

About

Weiwei Huang is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Weiwei Huang has authored 76 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 24 papers in Immunology and 15 papers in Epidemiology. Recurrent topics in Weiwei Huang's work include Immunotherapy and Immune Responses (10 papers), Cancer-related molecular mechanisms research (8 papers) and Bacterial Infections and Vaccines (7 papers). Weiwei Huang is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Cancer-related molecular mechanisms research (8 papers) and Bacterial Infections and Vaccines (7 papers). Weiwei Huang collaborates with scholars based in China, United States and Canada. Weiwei Huang's co-authors include Yanbing Ma, Wenjia Sun, Cunbao Liu, Xu Yang, Hongmei Bai, Qiong Long, Liangqun Hua, Yufeng Yao, Yang Li and Paul D. Cao and has published in prestigious journals such as Nucleic Acids Research, Advanced Materials and Nature Communications.

In The Last Decade

Weiwei Huang

73 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiwei Huang China 28 1.2k 464 448 427 376 76 2.4k
Karl Köhrer Germany 35 2.1k 1.7× 312 0.7× 168 0.4× 657 1.5× 487 1.3× 167 4.3k
Yongjun Yang China 26 948 0.8× 199 0.4× 265 0.6× 227 0.5× 518 1.4× 113 2.1k
Nicole C. Kesty United States 12 637 0.5× 231 0.5× 693 1.5× 358 0.8× 181 0.5× 15 2.0k
Ashok Kumar United States 36 986 0.8× 199 0.4× 267 0.6× 512 1.2× 1.2k 3.3× 109 3.6k
Erin E. Gill Canada 16 1.1k 0.9× 117 0.3× 684 1.5× 171 0.4× 453 1.2× 26 2.2k
Karen M. Frank United States 33 3.0k 2.4× 501 1.1× 133 0.3× 374 0.9× 528 1.4× 73 4.7k
Erwin Bohn Germany 31 1.6k 1.3× 183 0.4× 202 0.5× 354 0.8× 1.4k 3.7× 60 3.5k
Charlene M. Kahler Australia 30 825 0.7× 79 0.2× 1.0k 2.3× 725 1.7× 292 0.8× 89 2.5k
Mónica A. Delgado United States 26 1.5k 1.2× 157 0.3× 205 0.5× 1.9k 4.4× 875 2.3× 50 3.7k
Indrajit Chowdhury United States 19 926 0.7× 112 0.2× 141 0.3× 163 0.4× 268 0.7× 36 1.8k

Countries citing papers authored by Weiwei Huang

Since Specialization
Citations

This map shows the geographic impact of Weiwei Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Huang more than expected).

Fields of papers citing papers by Weiwei Huang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Huang. The network helps show where Weiwei Huang may publish in the future.

Co-authorship network of co-authors of Weiwei Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Huang. A scholar is included among the top collaborators of Weiwei Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Huang. Weiwei Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xue, Rui, Juan Wang, Weiwei Huang, et al.. (2025). Efficient production of recombinant hybrid mussel proteins with improved adhesion. International Journal of Biological Macromolecules. 289. 139937–139937. 3 indexed citations
2.
Liu, Yuhang, et al.. (2025). Study on high-concentration activated sludge system for energy-efficient nitrogen removal in wastewater. Sustainable Environment Research. 35(1).
3.
Xin, Kaiyun, Jingwen Zou, Yijie Zhang, et al.. (2024). Unveiling the A-to-I mRNA editing machinery and its regulation and evolution in fungi. Nature Communications. 15(1). 3934–3934. 13 indexed citations
4.
Long, Qiong, Peng Zheng, Xiao Zheng, et al.. (2022). Engineered bacterial membrane vesicles are promising carriers for vaccine design and tumor immunotherapy. Advanced Drug Delivery Reviews. 186. 114321–114321. 79 indexed citations
5.
Yang, Zhongqian, Liangqun Hua, Mengli Yang, et al.. (2022). Polymerized porin as a novel delivery platform for coronavirus vaccine. Journal of Nanobiotechnology. 20(1). 260–260. 4 indexed citations
6.
Huang, Weiwei, et al.. (2020). <p>Virus-Like Particles Presenting the FGF-2 Protein or Identified Antigenic Peptides Promoted Antitumor Immune Responses in Mice</p>. International Journal of Nanomedicine. Volume 15. 1983–1996. 11 indexed citations
7.
Guo, Xiaomin, Huan Wang, Yang Li, et al.. (2018). Transfection reagent Lipofectamine triggers type I interferon signaling activation in macrophages. Immunology and Cell Biology. 97(1). 92–96. 29 indexed citations
8.
Hao, Shuai, Shuang Li, Jing Wang, et al.. (2018). Phycocyanin Reduces Proliferation of Melanoma Cells through Downregulating GRB2/ERK Signaling. Journal of Agricultural and Food Chemistry. 66(41). 10921–10929. 27 indexed citations
9.
Chu, Xiaojie, Yang Li, Weiwei Huang, et al.. (2018). Combined immunization against TGF-β1 enhances HPV16 E7-specific vaccine-elicited antitumour immunity in mice with grafted TC-1 tumours. Artificial Cells Nanomedicine and Biotechnology. 46(sup2). 1199–1209. 7 indexed citations
10.
Wu, Shouquan, Weiwei Huang, Dan Wang, et al.. (2018). Evaluation of TLR2,TLR4, and TOLLIP polymorphisms for their role in tuberculosis susceptibility. Apmis. 126(6). 501–508. 17 indexed citations
11.
Wu, Dehua, Fei Deng, Jie Lei, et al.. (2017). Overexpression of KIAA1199: An independent prognostic marker in nonsmall cell lung cancer. Journal of Cancer Research and Therapeutics. 13(4). 664–664. 21 indexed citations
12.
Li, Yang, Xiaojie Chu, Cunbao Liu, et al.. (2017). Exogenous murine antimicrobial peptide CRAMP significantly exacerbates Ovalbumin-induced airway inflammation but ameliorates oxazolone-induced intestinal colitis in BALB/c mice. Human Vaccines & Immunotherapeutics. 14(1). 146–158. 9 indexed citations
14.
Liu, Cunbao, Yufeng Yao, Xu Yang, et al.. (2015). Production of Recombinant Human Papillomavirus Type 52 L1 Protein in Hansenula polymorpha Formed Virus-Like Particles. Journal of Microbiology and Biotechnology. 25(6). 936–940. 17 indexed citations
15.
Huang, Weiwei, Shijie Wang, Yufeng Yao, et al.. (2015). OmpW is a potential target for eliciting protective immunity against Acinetobacter baumannii infections. Vaccine. 33(36). 4479–4485. 63 indexed citations
16.
Ma, Yongqing, et al.. (2013). Maintaining and restoring cytoplasmic male sterility systems in pepper (Capsicum annuum L.). Genetics and Molecular Research. 12(3). 2320–2331. 11 indexed citations
17.
Zhao, Huiyan, et al.. (2012). The pollen wall and tapetum are altered in the cytoplasmic male sterile line RC7 of Chinese cabbage (Brassica campestris ssp pekinensis). Genetics and Molecular Research. 11(4). 4145–4156. 4 indexed citations
18.
Xiong, Wei, Yang Jiao, Weiwei Huang, et al.. (2012). Regulation of the cell cycle via mitochondrial gene expression and energy metabolism in HeLa cells. Acta Biochimica et Biophysica Sinica. 44(4). 347–358. 35 indexed citations
19.
Wan, Meimei, Weiwei Huang, Timothy E. Kute, et al.. (2012). Yin Yang 1 Plays an Essential Role in Breast Cancer and Negatively Regulates p27. American Journal Of Pathology. 180(5). 2120–2133. 77 indexed citations
20.
Huang, Weiwei, Philip J. Smaldino, Qiang Zhang, et al.. (2011). Yin Yang 1 contains G-quadruplex structures in its promoter and 5′-UTR and its expression is modulated by G4 resolvase 1. Nucleic Acids Research. 40(3). 1033–1049. 85 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026